NYSEAMERICAN:PTN Palatin Technologies (PTN) News Today $2.28 -0.02 (-0.87%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$2.25▼$2.4650-Day Range$2.10▼$3.1052-Week Range$2.08▼$9.48Volume33,619 shsAverage Volume76,983 shsMarket Capitalization$25.42 millionP/E RatioN/ADividend YieldN/APrice Target$50.00 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address PTN Media Mentions By Week PTN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTN News Sentiment▼0.000.70▲Average Medical News Sentiment PTN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTN Articles This Week▼01▲PTN Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePTN - Palatin Technologies, Inc.uk.finance.yahoo.com - May 30 at 9:15 PMPalatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte Conferencefinance.yahoo.com - May 30 at 8:29 AMPalatin Technologies (NYSEAMERICAN:PTN) Downgraded to Sell at StockNews.comamericanbankingnews.com - May 21 at 1:54 AMPalatin Technologies (NYSEAMERICAN:PTN) Announces Earnings Results, Misses Estimates By $0.24 EPSamericanbankingnews.com - May 19 at 9:49 AMPalatin Technologies (NYSE:PTN) Now Covered by Analysts at StockNews.comamericanbankingnews.com - May 19 at 6:36 AMPalatin Technologies, Inc. (AMEX:PTN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - May 17 at 3:11 PMQ3 2023 Palatin Technologies Inc Earnings Callfinance.yahoo.com - May 17 at 2:03 AMLadenburg Thalmann & Co. Sticks to Its Buy Rating for Palatin Technologies (PTN)markets.businessinsider.com - May 16 at 2:54 PMPalatin Technologies (PTN) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - May 16 at 2:11 PMPalatin Technologies, Inc. (PTN) Reports Q3 Loss, Tops Revenue Estimatesfinance.yahoo.com - May 16 at 10:30 AMPalatin Technologies Inc. Q3 Loss Narrowsmarkets.businessinsider.com - May 16 at 9:11 AMPalatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 16 at 9:11 AMHC Wainwright & Co. Reiterates Palatin Technologies (PTN) Buy Recommendationmsn.com - May 11 at 7:29 PMTELA Bio, Inc. (TELA) Reports Q1 Loss, Misses Revenue Estimatesfinance.yahoo.com - May 11 at 7:29 PMPalatin to Report Third Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on May 16, 2023finance.yahoo.com - May 11 at 6:05 PMAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and DermTech (DMTK)markets.businessinsider.com - May 9 at 8:29 AMPalatin Presents PL8177 Ulcerative Colitis Data at Digestive Disease Week Annual Conferencefinance.yahoo.com - May 9 at 8:29 AMPalatin Invites Investors to Listen to Replay of the PL9643 Dry Eye Disease Key Opinion Leader Webinarfinance.yahoo.com - May 8 at 6:24 PMPalatin Technologies to Host Key Opinion Leader Webinarfinance.yahoo.com - May 1 at 5:40 PMLadenburg Thalmann & Co. Keeps Their Buy Rating on Palatin Technologies (PTN)markets.businessinsider.com - May 1 at 7:39 AMPalatin Presents Initial Dry Eye Disease Phase 3 Clinical Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conferencefinance.yahoo.com - April 27 at 9:37 AMH.C. Wainwright Reaffirms Their Buy Rating on Palatin Technologies (PTN)markets.businessinsider.com - April 25 at 4:06 PMPalatin Presents Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conference Regarding a Potential Treatment for Glaucomafinance.yahoo.com - April 25 at 7:41 AMPalatin Announces Preliminary Third Quarter Fiscal 2023 Vyleesi® Product Revenue Resultsfinance.yahoo.com - April 19 at 9:47 AMCV Sciences (OTCMKTS:CVSI) & (NYSE:PTN) Financial Comparisonamericanbankingnews.com - April 19 at 3:30 AMPre-Clinical Data of Palatin's Melanocortin Agonist Demonstrating Therapeutic Effects in Diabetic Retinopathy and Uveitis Published in the International Journal of Molecular Sciencesfinance.yahoo.com - April 18 at 8:12 AMPalatin Technologies (NYSE:PTN) Shares Up 2.2%americanbankingnews.com - April 9 at 3:30 AMAnalysts Are Bullish on Top Healthcare Stocks: Palatin Technologies (PTN), Stryker (SYK)markets.businessinsider.com - March 13 at 5:37 PMFrontiers in Immunology Publishes Pre-Clinical Study of Palatin's Oral Formulation of PL8177 Demonstrating Therapeutic Effects in Inflammatory Bowel Diseasefinance.yahoo.com - March 2 at 9:30 AMPalatin Technologies Says USPTO Issues Patent On Vyleesi For Hypoactive Sexual Desire Disordermarkets.businessinsider.com - February 28 at 9:58 AMPalatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertensionfinance.yahoo.com - February 28 at 8:10 AMPalatin Technologies Earnings Perspective: Return On Capital Employedbenzinga.com - February 16 at 10:39 AMAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Lantheus (LNTH)markets.businessinsider.com - February 15 at 2:51 PMPalatin Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - February 15 at 9:50 AMEarnings Outlook For Palatin Technologiesmsn.com - February 14 at 3:58 PMPalatin to Report Second Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on February 15, 2023finance.yahoo.com - February 10 at 8:46 AMMyovant Sciences (MYOV) Reports Q3 Loss, Lags Revenue Estimatesfinance.yahoo.com - January 26 at 7:03 PMPalatin starts mid-stage study of bremelanotide for diabetic kidney diseasemsn.com - January 19 at 1:56 PMPalatin Initiates Enrollment in the Phase 2 Bremelanotide BREAKOUT Study in Patients with Diabetic Kidney Diseasefinance.yahoo.com - January 19 at 7:36 AMPalatin Technologies Shares Jump on $4.7 Million Funding Newsmarketwatch.com - January 18 at 9:36 PMPalatin Receives $4.7 Million of Non-Dilutive Fundingfinance.yahoo.com - January 18 at 7:38 AMFrontiers in Immunology Publishes Pre-Clinical Study of Palatin's PL8177 Demonstrating Therapeutic Effects in Inflammatory Conditionsfinance.yahoo.com - January 10 at 8:02 AMPalatin Announces Preliminary Second Quarter Fiscal 2023 Vyleesi® Product Sales Resultsfinance.yahoo.com - January 5 at 7:43 AMPalatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatmentthestreet.com - January 5 at 12:12 AMPalatin Technologies's Return On Capital Employed Insightsbenzinga.com - December 23 at 2:37 PMPalatin Technologies, Inc. (PTN) Q1 2023 Earnings Call Transcriptseekingalpha.com - November 14 at 2:29 PMPalatin Technologies, Inc. (PTN) Reports Q1 Loss, Tops Revenue Estimatesfinance.yahoo.com - November 14 at 12:09 PMPalatin Technologies Inc. Q1 Loss increases, but beats estimatesmarkets.businessinsider.com - November 14 at 9:29 AMPalatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 9:29 AMSolid Biosciences Inc. (SLDB) Reports Q3 Loss, Lags Revenue Estimatesfinance.yahoo.com - November 10 at 12:22 PM Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IGXT News KA News HBPCF News IMPL News SIOX News VBIV News VTGN News CRPOF News RGLS News ANGN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NYSEAMERICAN:PTN) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.